Mary E. Donohoe

2.4k total citations
30 papers, 1.9k citations indexed

About

Mary E. Donohoe is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Mary E. Donohoe has authored 30 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 9 papers in Genetics and 5 papers in Immunology. Recurrent topics in Mary E. Donohoe's work include Epigenetics and DNA Methylation (6 papers), Genomics and Chromatin Dynamics (6 papers) and Protein Degradation and Inhibitors (5 papers). Mary E. Donohoe is often cited by papers focused on Epigenetics and DNA Methylation (6 papers), Genomics and Chromatin Dynamics (6 papers) and Protein Degradation and Inhibitors (5 papers). Mary E. Donohoe collaborates with scholars based in United States, Netherlands and Germany. Mary E. Donohoe's co-authors include Jeannie T. Lee, Yang Shi, Na Xu, Yasunao Kamikawa, Tao Wu, John D. Biggers, Lynda K. McGinnis, En Li, Xiaolin Zhang and Stefan F. Pinter and has published in prestigious journals such as Nature, Cell and Nature Communications.

In The Last Decade

Mary E. Donohoe

27 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary E. Donohoe United States 16 1.6k 458 311 242 175 30 1.9k
Frédérique Gay United States 14 2.6k 1.6× 677 1.5× 286 0.9× 226 0.9× 165 0.9× 14 2.9k
Jun Shinga Japan 19 2.0k 1.2× 549 1.2× 170 0.5× 216 0.9× 304 1.7× 28 2.4k
Kunal Rai United States 18 1.6k 1.0× 327 0.7× 339 1.1× 357 1.5× 200 1.1× 44 2.0k
Kristina Vintersten Germany 19 1.8k 1.1× 444 1.0× 137 0.4× 190 0.8× 185 1.1× 84 2.3k
Andrei Kuzmichev United States 9 2.6k 1.6× 373 0.8× 264 0.8× 209 0.9× 120 0.7× 9 2.9k
Marc A. Morgan United States 25 2.2k 1.4× 257 0.6× 253 0.8× 170 0.7× 146 0.8× 38 2.6k
Mads Lerdrup Denmark 24 2.3k 1.5× 316 0.7× 192 0.6× 421 1.7× 205 1.2× 32 2.9k
Duncan Sproul United Kingdom 21 2.5k 1.6× 450 1.0× 382 1.2× 157 0.6× 165 0.9× 35 2.9k
Hannah K. Long United Kingdom 12 2.3k 1.4× 397 0.9× 219 0.7× 139 0.6× 118 0.7× 18 2.5k
Carmen Brenner Belgium 9 2.1k 1.3× 302 0.7× 440 1.4× 224 0.9× 184 1.1× 10 2.4k

Countries citing papers authored by Mary E. Donohoe

Since Specialization
Citations

This map shows the geographic impact of Mary E. Donohoe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary E. Donohoe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary E. Donohoe more than expected).

Fields of papers citing papers by Mary E. Donohoe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary E. Donohoe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary E. Donohoe. The network helps show where Mary E. Donohoe may publish in the future.

Co-authorship network of co-authors of Mary E. Donohoe

This figure shows the co-authorship network connecting the top 25 collaborators of Mary E. Donohoe. A scholar is included among the top collaborators of Mary E. Donohoe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary E. Donohoe. Mary E. Donohoe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Tao & Mary E. Donohoe. (2019). Yy1 regulates Senp1 contributing to AMPA receptor GluR1 expression following neuronal depolarization. Journal of Biomedical Science. 26(1). 79–79. 17 indexed citations
2.
Miao, Nan, Seung‐Nam Kim, Tao Wu, et al.. (2018). Long noncoding RNA Sox2ot and transcription factor YY1 co-regulate the differentiation of cortical neural progenitors by repressing Sox2. Cell Death and Disease. 9(8). 799–799. 68 indexed citations
3.
Wu, Tao, Yasunao Kamikawa, & Mary E. Donohoe. (2018). Brd4’s Bromodomains Mediate Histone H3 Acetylation and Chromatin Remodeling in Pluripotent Cells through P300 and Brg1. Cell Reports. 25(7). 1756–1771. 85 indexed citations
4.
Jamieson, Catriona, Maria T. Millan, Abla A. Creasey, et al.. (2018). CIRM Alpha Stem Cell Clinics: Collaboratively Addressing Regenerative Medicine Challenges. Cell stem cell. 22(6). 801–805. 5 indexed citations
5.
Fischer, Delaney K., et al.. (2017). Altered reward sensitivity in female offspring of cocaine-exposed fathers. Behavioural Brain Research. 332. 23–31. 30 indexed citations
6.
Wu, Tao & Mary E. Donohoe. (2016). Sequential chromatin immunoprecipitation to detect SUMOylated MeCP2 in neurons. Biochemistry and Biophysics Reports. 5. 374–378. 3 indexed citations
7.
Wu, Tao, Hugo Pinto, Yasunao Kamikawa, & Mary E. Donohoe. (2015). The BET Family Member BRD4 Interacts with OCT4 and Regulates Pluripotency Gene Expression. Stem Cell Reports. 4(3). 390–403. 66 indexed citations
8.
Kamikawa, Yasunao & Mary E. Donohoe. (2015). Histone Demethylation Maintains Prdm14 and Tsix Expression and Represses Xist in Embryonic Stem Cells. PLoS ONE. 10(5). e0125626–e0125626. 9 indexed citations
9.
Lizama, Carlos O., John S. Hawkins, Frank L. Bos, et al.. (2015). Repression of arterial genes in hemogenic endothelium is sufficient for haematopoietic fate acquisition. Nature Communications. 6(1). 7739–7739. 103 indexed citations
10.
Wu, Tao & Mary E. Donohoe. (2015). The converging roles of BRD4 and gene transcription in pluripotency and oncogenesis. PubMed. 2(3). 6 indexed citations
11.
Kamikawa, Yasunao & Mary E. Donohoe. (2014). The localization of histone H3K27me3 demethylase Jmjd3 is dynamically regulated. Epigenetics. 9(6). 834–841. 28 indexed citations
12.
Sleiman, Sama F., Manuela Basso, Lata Mahishi, et al.. (2009). Putting the ‘HAT’ back on survival signalling: the promises and challenges of HDAC inhibition in the treatment of neurological conditions. Expert Opinion on Investigational Drugs. 18(5). 573–584. 63 indexed citations
13.
Donohoe, Mary E., et al.. (2009). The pluripotency factor Oct4 interacts with Ctcf and also controls X-chromosome pairing and counting. Nature. 460(7251). 128–132. 223 indexed citations
14.
Lindroth, Anders M., Yoon Jung Park, Chelsea McLean, et al.. (2008). Antagonism between DNA and H3K27 Methylation at the Imprinted Rasgrf1 Locus. PLoS Genetics. 4(8). e1000145–e1000145. 94 indexed citations
15.
Donohoe, Mary E., Li‐Feng Zhang, Na Xu, Yang Shi, & Jeannie T. Lee. (2007). Identification of a Ctcf Cofactor, Yy1, for the X Chromosome Binary Switch. Molecular Cell. 25(1). 43–56. 195 indexed citations
16.
Xu, Na, et al.. (2007). Evidence that homologous X-chromosome pairing requires transcription and Ctcf protein. Nature Genetics. 39(11). 1390–1396. 151 indexed citations
17.
Sui, Guangchao, El Bachir Affar, Yujiang Geno Shi, et al.. (2004). Yin Yang 1 Is a Negative Regulator of p53. Cell. 117(7). 859–872. 357 indexed citations
18.
Donohoe, Mary E., Gabriele Beck‐Engeser, Nils Lönberg, et al.. (2000). Transgenic Human λ5 Rescues the Murine λ5 Nullizygous Phenotype. The Journal of Immunology. 164(10). 5269–5276. 1 indexed citations
19.
Donohoe, Mary E., Xiaolin Zhang, Lynda K. McGinnis, et al.. (1999). Targeted Disruption of Mouse Yin Yang 1 Transcription Factor Results in Peri-Implantation Lethality. Molecular and Cellular Biology. 19(10). 7237–7244. 311 indexed citations
20.
Donohoe, Mary E. & Bonnie B. Blomberg. (1997). The 14.1 surrogate light chain promoter has lineage- and stage-restricted activity. The Journal of Immunology. 158(4). 1681–1691. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026